Similarly, the small-molecule inhibitor RITA (reactivation of p53 and induction of tumour cellapoptosis) binds p53 andthereby also prevents its interaction with MDM2 and the subsequent degradation of p53 (ref. 23). Here, MDM2 is linked to neoplasm.